| Gene symbol | CTAG1B | Synonyms | CTAG, ESO1, CT6.1, CTAG1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | cancer/testis antigen 1B | ||||
| GTO ID | GTC0521 |
| Trial ID | NCT04318964 |
| Disease | Synovial Sarcoma | Liposarcoma |
| Altered gene | NY-ESO-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | TAEST16001 cells |
| HLA | HLA-A*02:01 |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | An Open, Single Arm and Early Clinical Study of TAEST16001 in the Treatment of Solid Tumor Mainly Containing Soft Tissue Sarcoma With Positive Expression of Tumor Antigen NY-ESO-1 (HLA-A * 02:01) |
| Year | 2020 |
| Country | China |
| Company sponsor | Sun Yat-sen University |
| Other ID(s) | SunYat-senU-TAEST16001 |
| Vector information | |||||||||
|
|||||||||
| Cohort1: synovial sarcoma | |||||||||||||||||
|
|||||||||||||||||
| Cohort2: liposarcoma | |||||||||||||||||
|
|||||||||||||||||